Sabra Provides Update on Genesis Exodus; Reaffirms 2017 and 2018 Guidance
Nov 14, 2017 00:49 am UTC| Business
IRVINE, Calif., Nov. 13, 2017 -- On November 8, 2017, Sabra Health Care REIT, Inc. (NASDAQ:SBRA) (NASDAQ:SBRAP) and Genesis Healthcare, Inc. (“Genesis”) entered into a memorandum of understanding (the “Genesis Exodus...
Military Order of the Purple Heart Honors America’s Veterans
Nov 14, 2017 00:32 am UTC| Business
WASHINGTON, DC, Nov. 13, 2017 -- On Saturday, November 11, the leadership of the Military Order of the Purple Heart paid homage to the Veterans of all generations at each of the War Memorials in Washington, DC to mark...
A. M. Castle & Co. Reports Post-Emergence Results
Nov 14, 2017 00:30 am UTC| Business
OAK BROOK, Ill., Nov. 13, 2017 -- A. M. Castle Co. (OTCQB:CTAM) (the "Company" or "Castle"), a global distributor of specialty metal and supply chain solutions, today reported financial results for the one-month period...
Nov 14, 2017 00:23 am UTC| Business
Expert Advisory Board Endorses Randomized Phase I/II Trial in Newly Diagnosed Stage III and IV Ovarian Cancer GEN-1 Immunotherapy to Enter Phase I/II Clinical Study in the First Half of 2018 Following a Phase IB Trial...
Nov 14, 2017 00:15 am UTC| Business
SOUTH SAN FRANCISCO, Calif., Nov. 13, 2017 -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases,...
Nov 14, 2017 00:00 am UTC| Business
CALGARY, Alberta, Nov. 13, 2017 -- Canacol Energy Ltd. (“Canacol” or the “Corporation”) (TSX:CNE) (OTCQX:CNNEF) (BVC:CNEC) will announce its third quarter 2017 financial results after the market close on November 14,...
DCP Midstream Announces Pricing of Series A Preferred Units
Nov 13, 2017 23:59 pm UTC| Business
DENVER, Nov. 13, 2017 -- DCP Midstream, LP (NYSE:DCP) (“DCP”) announced today that it has priced an underwritten public offering of 500,000 of its 7.375% Series A Fixed-to-Floating Rate Cumulative Redeemable Perpetual...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update